Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
POSITIVE REGULATION OF GENE EXPRESSION |
40 |
1733 |
2.135e-22 |
4.966e-19 |
2 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
37 |
1381 |
1.086e-22 |
4.966e-19 |
3 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
40 |
1805 |
9.572e-22 |
1.485e-18 |
4 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
30 |
1004 |
2.34e-19 |
2.722e-16 |
5 |
RESPONSE TO ENDOGENOUS STIMULUS |
34 |
1450 |
7.763e-19 |
7.224e-16 |
6 |
REGULATION OF CELL DEATH |
33 |
1472 |
1.209e-17 |
9.377e-15 |
7 |
RESPONSE TO LIPID |
27 |
888 |
1.584e-17 |
1.053e-14 |
8 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
35 |
1784 |
5.336e-17 |
3.104e-14 |
9 |
WOUND HEALING |
21 |
470 |
6.326e-17 |
3.271e-14 |
10 |
RESPONSE TO WOUNDING |
22 |
563 |
1.684e-16 |
6.386e-14 |
11 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
25 |
799 |
1.732e-16 |
6.386e-14 |
12 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
35 |
1848 |
1.601e-16 |
6.386e-14 |
13 |
REGULATION OF CELL PROLIFERATION |
32 |
1496 |
1.784e-16 |
6.386e-14 |
14 |
RESPONSE TO MOLECULE OF BACTERIAL ORIGIN |
18 |
321 |
2.763e-16 |
9.183e-14 |
15 |
NEGATIVE REGULATION OF CELL DEATH |
25 |
872 |
1.311e-15 |
4.067e-13 |
16 |
REGULATION OF CELL ADHESION |
22 |
629 |
1.681e-15 |
4.889e-13 |
17 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
30 |
1395 |
1.951e-15 |
5.34e-13 |
18 |
RESPONSE TO HORMONE |
25 |
893 |
2.266e-15 |
5.859e-13 |
19 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
22 |
643 |
2.647e-15 |
6.483e-13 |
20 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
29 |
1360 |
8.481e-15 |
1.973e-12 |
21 |
IMMUNE SYSTEM PROCESS |
34 |
1984 |
1.063e-14 |
2.355e-12 |
22 |
REGULATION OF CELL DIFFERENTIATION |
30 |
1492 |
1.175e-14 |
2.486e-12 |
23 |
REGULATION OF IMMUNE SYSTEM PROCESS |
29 |
1403 |
1.893e-14 |
3.671e-12 |
24 |
TISSUE DEVELOPMENT |
30 |
1518 |
1.859e-14 |
3.671e-12 |
25 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
31 |
1672 |
3.249e-14 |
6.047e-12 |
26 |
CELL ACTIVATION |
20 |
568 |
3.58e-14 |
6.406e-12 |
27 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
24 |
917 |
4.134e-14 |
7.125e-12 |
28 |
RESPONSE TO EXTERNAL STIMULUS |
32 |
1821 |
4.659e-14 |
7.743e-12 |
29 |
REGULATION OF CELL CELL ADHESION |
17 |
380 |
8.378e-14 |
1.299e-11 |
30 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
13 |
167 |
8.244e-14 |
1.299e-11 |
31 |
RESPONSE TO NITROGEN COMPOUND |
23 |
859 |
9.898e-14 |
1.486e-11 |
32 |
LYMPHOCYTE ACTIVATION |
16 |
342 |
2.482e-13 |
3.609e-11 |
33 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
24 |
1008 |
3.217e-13 |
4.537e-11 |
34 |
POSITIVE REGULATION OF LOCOMOTION |
17 |
420 |
4.231e-13 |
5.79e-11 |
35 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
25 |
1142 |
5.878e-13 |
7.815e-11 |
36 |
REGULATION OF HOMOTYPIC CELL CELL ADHESION |
15 |
307 |
8.054e-13 |
1.041e-10 |
37 |
RESPONSE TO BACTERIUM |
18 |
528 |
1.429e-12 |
1.797e-10 |
38 |
LYMPHOCYTE DIFFERENTIATION |
13 |
209 |
1.479e-12 |
1.811e-10 |
39 |
IMMUNE RESPONSE |
24 |
1100 |
2.086e-12 |
2.489e-10 |
40 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
21 |
801 |
2.204e-12 |
2.563e-10 |
41 |
RESPONSE TO PEPTIDE |
16 |
404 |
3.139e-12 |
3.562e-10 |
42 |
REGULATION OF CELL ACTIVATION |
17 |
484 |
4.083e-12 |
4.524e-10 |
43 |
LEUKOCYTE ACTIVATION |
16 |
414 |
4.539e-12 |
4.912e-10 |
44 |
REGULATION OF DEFENSE RESPONSE |
20 |
759 |
7.467e-12 |
7.897e-10 |
45 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
28 |
1656 |
8.376e-12 |
8.635e-10 |
46 |
RESPONSE TO ALCOHOL |
15 |
362 |
8.537e-12 |
8.635e-10 |
47 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
20 |
771 |
9.914e-12 |
9.815e-10 |
48 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
24 |
1192 |
1.137e-11 |
1.103e-09 |
49 |
RESPONSE TO BIOTIC STIMULUS |
21 |
886 |
1.479e-11 |
1.349e-09 |
50 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
20 |
788 |
1.469e-11 |
1.349e-09 |
51 |
CIRCULATORY SYSTEM DEVELOPMENT |
20 |
788 |
1.469e-11 |
1.349e-09 |
52 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
18 |
609 |
1.533e-11 |
1.372e-09 |
53 |
REGULATION OF RESPONSE TO STRESS |
26 |
1468 |
2.166e-11 |
1.902e-09 |
54 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
19 |
724 |
2.952e-11 |
2.544e-09 |
55 |
POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
11 |
162 |
3.408e-11 |
2.883e-09 |
56 |
MORPHOGENESIS OF AN EPITHELIUM |
15 |
400 |
3.503e-11 |
2.91e-09 |
57 |
EMBRYONIC ORGAN DEVELOPMENT |
15 |
406 |
4.318e-11 |
3.525e-09 |
58 |
EPITHELIUM DEVELOPMENT |
21 |
945 |
4.918e-11 |
3.945e-09 |
59 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
29 |
1929 |
5.446e-11 |
4.256e-09 |
60 |
REGULATION OF RESPONSE TO WOUNDING |
15 |
413 |
5.489e-11 |
4.256e-09 |
61 |
RESPONSE TO STEROID HORMONE |
16 |
497 |
6.936e-11 |
5.29e-09 |
62 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
20 |
876 |
9.723e-11 |
7.297e-09 |
63 |
LEUKOCYTE DIFFERENTIATION |
13 |
292 |
9.907e-11 |
7.317e-09 |
64 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
21 |
983 |
1.019e-10 |
7.411e-09 |
65 |
REGULATION OF INFLAMMATORY RESPONSE |
13 |
294 |
1.078e-10 |
7.718e-09 |
66 |
POSITIVE REGULATION OF CELL CELL ADHESION |
12 |
243 |
1.687e-10 |
1.189e-08 |
67 |
POSITIVE REGULATION OF CELL ADHESION |
14 |
376 |
1.865e-10 |
1.295e-08 |
68 |
MESENCHYME DEVELOPMENT |
11 |
190 |
1.902e-10 |
1.302e-08 |
69 |
NEGATIVE REGULATION OF GENE EXPRESSION |
25 |
1493 |
1.966e-10 |
1.307e-08 |
70 |
TISSUE MORPHOGENESIS |
16 |
533 |
1.939e-10 |
1.307e-08 |
71 |
POSITIVE REGULATION OF CELL PROLIFERATION |
19 |
814 |
2.165e-10 |
1.419e-08 |
72 |
CELLULAR RESPONSE TO LIPID |
15 |
457 |
2.251e-10 |
1.455e-08 |
73 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
20 |
926 |
2.587e-10 |
1.638e-08 |
74 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
19 |
823 |
2.605e-10 |
1.638e-08 |
75 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
25 |
1517 |
2.752e-10 |
1.707e-08 |
76 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
16 |
552 |
3.235e-10 |
1.955e-08 |
77 |
VASCULATURE DEVELOPMENT |
15 |
469 |
3.223e-10 |
1.955e-08 |
78 |
CELL MOTILITY |
19 |
835 |
3.322e-10 |
1.957e-08 |
79 |
LOCALIZATION OF CELL |
19 |
835 |
3.322e-10 |
1.957e-08 |
80 |
GLAND DEVELOPMENT |
14 |
395 |
3.552e-10 |
2.066e-08 |
81 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
18 |
740 |
3.647e-10 |
2.095e-08 |
82 |
ORGAN MORPHOGENESIS |
19 |
841 |
3.746e-10 |
2.126e-08 |
83 |
POSITIVE REGULATION OF STAT CASCADE |
8 |
73 |
4.059e-10 |
2.248e-08 |
84 |
POSITIVE REGULATION OF JAK STAT CASCADE |
8 |
73 |
4.059e-10 |
2.248e-08 |
85 |
RESPONSE TO INSULIN |
11 |
205 |
4.282e-10 |
2.344e-08 |
86 |
REGULATION OF LEUKOCYTE PROLIFERATION |
11 |
206 |
4.509e-10 |
2.44e-08 |
87 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
14 |
408 |
5.414e-10 |
2.896e-08 |
88 |
POSITIVE REGULATION OF PROTEIN SECRETION |
11 |
211 |
5.819e-10 |
3.077e-08 |
89 |
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS |
19 |
867 |
6.233e-10 |
3.259e-08 |
90 |
REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
11 |
213 |
6.431e-10 |
3.325e-08 |
91 |
CELLULAR RESPONSE TO BIOTIC STIMULUS |
10 |
163 |
7.655e-10 |
3.914e-08 |
92 |
STAT CASCADE |
7 |
50 |
9.099e-10 |
4.552e-08 |
93 |
JAK STAT CASCADE |
7 |
50 |
9.099e-10 |
4.552e-08 |
94 |
LOCOMOTION |
21 |
1114 |
9.961e-10 |
4.931e-08 |
95 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
21 |
1135 |
1.394e-09 |
6.825e-08 |
96 |
RESPONSE TO ABIOTIC STIMULUS |
20 |
1024 |
1.488e-09 |
7.213e-08 |
97 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
22 |
1275 |
1.883e-09 |
9.032e-08 |
98 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
9 |
131 |
2.094e-09 |
9.94e-08 |
99 |
INFLAMMATORY RESPONSE |
14 |
454 |
2.15e-09 |
1.011e-07 |
100 |
POSITIVE REGULATION OF CELL ACTIVATION |
12 |
311 |
2.81e-09 |
1.307e-07 |
101 |
TUBE DEVELOPMENT |
15 |
552 |
2.993e-09 |
1.379e-07 |
102 |
REGULATION OF HEMOPOIESIS |
12 |
314 |
3.13e-09 |
1.428e-07 |
103 |
TUBE MORPHOGENESIS |
12 |
323 |
4.3e-09 |
1.942e-07 |
104 |
CELL PROLIFERATION |
16 |
672 |
5.473e-09 |
2.449e-07 |
105 |
IMMUNE SYSTEM DEVELOPMENT |
15 |
582 |
6.108e-09 |
2.707e-07 |
106 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
23 |
1492 |
6.333e-09 |
2.78e-07 |
107 |
REGULATION OF FAT CELL DIFFERENTIATION |
8 |
106 |
8.216e-09 |
3.573e-07 |
108 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
14 |
505 |
8.345e-09 |
3.595e-07 |
109 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
15 |
602 |
9.604e-09 |
4.1e-07 |
110 |
NEGATIVE REGULATION OF RESPONSE TO WOUNDING |
9 |
156 |
9.765e-09 |
4.131e-07 |
111 |
NEGATIVE REGULATION OF CELL ACTIVATION |
9 |
158 |
1.092e-08 |
4.576e-07 |
112 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
19 |
1036 |
1.16e-08 |
4.775e-07 |
113 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
19 |
1036 |
1.16e-08 |
4.775e-07 |
114 |
RESPONSE TO ESTROGEN |
10 |
218 |
1.27e-08 |
5.183e-07 |
115 |
REPRODUCTION |
21 |
1297 |
1.477e-08 |
5.976e-07 |
116 |
CELLULAR RESPONSE TO ALCOHOL |
8 |
115 |
1.567e-08 |
6.267e-07 |
117 |
NEGATIVE REGULATION OF CELL ADHESION |
10 |
223 |
1.576e-08 |
6.267e-07 |
118 |
BLOOD VESSEL MORPHOGENESIS |
12 |
364 |
1.628e-08 |
6.419e-07 |
119 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
24 |
1710 |
1.68e-08 |
6.568e-07 |
120 |
REGULATION OF CELL DEVELOPMENT |
17 |
836 |
1.763e-08 |
6.836e-07 |
121 |
REGULATION OF GROWTH |
15 |
633 |
1.873e-08 |
7.204e-07 |
122 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
13 |
465 |
2.737e-08 |
1.044e-06 |
123 |
EMBRYO DEVELOPMENT |
17 |
894 |
4.689e-08 |
1.774e-06 |
124 |
POSITIVE REGULATION OF CELL COMMUNICATION |
22 |
1532 |
5.305e-08 |
1.991e-06 |
125 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
18 |
1021 |
5.543e-08 |
2.063e-06 |
126 |
NEGATIVE REGULATION OF CELL CELL ADHESION |
8 |
138 |
6.542e-08 |
2.416e-06 |
127 |
REGULATION OF JAK STAT CASCADE |
8 |
144 |
9.104e-08 |
3.284e-06 |
128 |
NEGATIVE REGULATION OF DEFENSE RESPONSE |
8 |
144 |
9.104e-08 |
3.284e-06 |
129 |
REGULATION OF STAT CASCADE |
8 |
144 |
9.104e-08 |
3.284e-06 |
130 |
POSITIVE REGULATION OF CYTOKINE SECRETION |
7 |
96 |
9.41e-08 |
3.368e-06 |
131 |
GLAND MORPHOGENESIS |
7 |
97 |
1.011e-07 |
3.591e-06 |
132 |
REGULATION OF T CELL PROLIFERATION |
8 |
147 |
1.068e-07 |
3.765e-06 |
133 |
CELLULAR RESPONSE TO PEPTIDE |
10 |
274 |
1.096e-07 |
3.806e-06 |
134 |
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
10 |
274 |
1.096e-07 |
3.806e-06 |
135 |
REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS |
6 |
59 |
1.106e-07 |
3.812e-06 |
136 |
REGULATION OF CYTOKINE SECRETION |
8 |
149 |
1.186e-07 |
4.057e-06 |
137 |
NEGATIVE REGULATION OF INFLAMMATORY RESPONSE |
7 |
100 |
1.248e-07 |
4.239e-06 |
138 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
22 |
1618 |
1.39e-07 |
4.685e-06 |
139 |
NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION |
7 |
102 |
1.431e-07 |
4.79e-06 |
140 |
EMBRYONIC MORPHOGENESIS |
13 |
539 |
1.523e-07 |
5.051e-06 |
141 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
7 |
103 |
1.531e-07 |
5.051e-06 |
142 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
10 |
285 |
1.58e-07 |
5.178e-06 |
143 |
REGULATION OF IMMUNE RESPONSE |
16 |
858 |
1.624e-07 |
5.283e-06 |
144 |
DEFENSE RESPONSE |
19 |
1231 |
1.779e-07 |
5.748e-06 |
145 |
POSITIVE REGULATION OF CYTOKINE PRODUCTION |
11 |
370 |
1.923e-07 |
6.129e-06 |
146 |
POSITIVE REGULATION OF SECRETION |
11 |
370 |
1.923e-07 |
6.129e-06 |
147 |
REGENERATION |
8 |
161 |
2.153e-07 |
6.816e-06 |
148 |
POSITIVE REGULATION OF RESPONSE TO WOUNDING |
8 |
162 |
2.258e-07 |
7.1e-06 |
149 |
REGULATION OF MAPK CASCADE |
14 |
660 |
2.304e-07 |
7.195e-06 |
150 |
NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS |
5 |
35 |
2.347e-07 |
7.28e-06 |
151 |
UROGENITAL SYSTEM DEVELOPMENT |
10 |
299 |
2.462e-07 |
7.587e-06 |
152 |
REGULATION OF CYTOKINE PRODUCTION |
13 |
563 |
2.508e-07 |
7.677e-06 |
153 |
POSITIVE REGULATION OF MAPK CASCADE |
12 |
470 |
2.628e-07 |
7.992e-06 |
154 |
REGULATION OF EPITHELIAL CELL MIGRATION |
8 |
166 |
2.722e-07 |
8.226e-06 |
155 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
12 |
472 |
2.75e-07 |
8.255e-06 |
156 |
REGULATION OF LEUKOCYTE DIFFERENTIATION |
9 |
232 |
2.964e-07 |
8.841e-06 |
157 |
REGULATION OF PROTEIN SECRETION |
11 |
389 |
3.169e-07 |
9.391e-06 |
158 |
IN UTERO EMBRYONIC DEVELOPMENT |
10 |
311 |
3.536e-07 |
1.035e-05 |
159 |
HEMOSTASIS |
10 |
311 |
3.536e-07 |
1.035e-05 |
160 |
SECRETION BY CELL |
12 |
486 |
3.755e-07 |
1.085e-05 |
161 |
IMMUNE EFFECTOR PROCESS |
12 |
486 |
3.755e-07 |
1.085e-05 |
162 |
RESPONSE TO CORTICOSTEROID |
8 |
176 |
4.255e-07 |
1.222e-05 |
163 |
SENSORY ORGAN DEVELOPMENT |
12 |
493 |
4.371e-07 |
1.248e-05 |
164 |
EPITHELIAL CELL DIFFERENTIATION |
12 |
495 |
4.563e-07 |
1.295e-05 |
165 |
REGULATION OF SECRETION |
14 |
699 |
4.604e-07 |
1.298e-05 |
166 |
ENDOCRINE SYSTEM DEVELOPMENT |
7 |
123 |
5.156e-07 |
1.445e-05 |
167 |
POSITIVE REGULATION OF TRANSPORT |
16 |
936 |
5.224e-07 |
1.456e-05 |
168 |
NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION |
5 |
41 |
5.319e-07 |
1.468e-05 |
169 |
GROWTH |
11 |
410 |
5.332e-07 |
1.468e-05 |
170 |
INOSITOL LIPID MEDIATED SIGNALING |
7 |
124 |
5.447e-07 |
1.491e-05 |
171 |
REGULATION OF BODY FLUID LEVELS |
12 |
506 |
5.759e-07 |
1.567e-05 |
172 |
RENAL TUBULE DEVELOPMENT |
6 |
78 |
5.946e-07 |
1.609e-05 |
173 |
LEUKOCYTE CELL CELL ADHESION |
9 |
255 |
6.553e-07 |
1.762e-05 |
174 |
DEVELOPMENTAL GROWTH |
10 |
333 |
6.605e-07 |
1.766e-05 |
175 |
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
12 |
514 |
6.796e-07 |
1.807e-05 |
176 |
METANEPHROS DEVELOPMENT |
6 |
81 |
7.444e-07 |
1.95e-05 |
177 |
LEUKOCYTE MIGRATION |
9 |
259 |
7.461e-07 |
1.95e-05 |
178 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
17 |
1087 |
7.502e-07 |
1.95e-05 |
179 |
REGULATION OF IMMUNE EFFECTOR PROCESS |
11 |
424 |
7.42e-07 |
1.95e-05 |
180 |
REGULATION OF DNA METABOLIC PROCESS |
10 |
340 |
7.98e-07 |
2.058e-05 |
181 |
KIDNEY MORPHOGENESIS |
6 |
82 |
8.007e-07 |
2.058e-05 |
182 |
B CELL ACTIVATION |
7 |
132 |
8.318e-07 |
2.115e-05 |
183 |
MAINTENANCE OF CELL NUMBER |
7 |
132 |
8.318e-07 |
2.115e-05 |
184 |
EMBRYONIC PLACENTA DEVELOPMENT |
6 |
83 |
8.604e-07 |
2.176e-05 |
185 |
AGING |
9 |
264 |
8.748e-07 |
2.2e-05 |
186 |
REGULATION OF TRANSPORT |
22 |
1804 |
9.034e-07 |
2.26e-05 |
187 |
EAR DEVELOPMENT |
8 |
195 |
9.253e-07 |
2.302e-05 |
188 |
RESPIRATORY SYSTEM DEVELOPMENT |
8 |
197 |
9.993e-07 |
2.473e-05 |
189 |
POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION |
7 |
136 |
1.017e-06 |
2.492e-05 |
190 |
GLIAL CELL DIFFERENTIATION |
7 |
136 |
1.017e-06 |
2.492e-05 |
191 |
RESPONSE TO EXTRACELLULAR STIMULUS |
11 |
441 |
1.09e-06 |
2.656e-05 |
192 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
7 |
138 |
1.122e-06 |
2.692e-05 |
193 |
NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY |
8 |
200 |
1.12e-06 |
2.692e-05 |
194 |
PLACENTA DEVELOPMENT |
7 |
138 |
1.122e-06 |
2.692e-05 |
195 |
TISSUE REMODELING |
6 |
87 |
1.137e-06 |
2.713e-05 |
196 |
REGULATION OF STEM CELL PROLIFERATION |
6 |
88 |
1.216e-06 |
2.888e-05 |
197 |
B CELL DIFFERENTIATION |
6 |
89 |
1.3e-06 |
3.071e-05 |
198 |
MESONEPHROS DEVELOPMENT |
6 |
90 |
1.389e-06 |
3.264e-05 |
199 |
POSITIVE REGULATION OF STEM CELL DIFFERENTIATION |
5 |
50 |
1.463e-06 |
3.422e-05 |
200 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
12 |
554 |
1.49e-06 |
3.464e-05 |
201 |
REGULATION OF CELLULAR LOCALIZATION |
18 |
1277 |
1.497e-06 |
3.464e-05 |
202 |
RESPONSE TO ESTRADIOL |
7 |
146 |
1.638e-06 |
3.756e-05 |
203 |
CELLULAR RESPONSE TO INSULIN STIMULUS |
7 |
146 |
1.638e-06 |
3.756e-05 |
204 |
NEGATIVE REGULATION OF CYTOKINE PRODUCTION |
8 |
211 |
1.673e-06 |
3.816e-05 |
205 |
INTRACELLULAR SIGNAL TRANSDUCTION |
20 |
1572 |
1.697e-06 |
3.853e-05 |
206 |
TAXIS |
11 |
464 |
1.787e-06 |
4.02e-05 |
207 |
ADAPTIVE IMMUNE RESPONSE |
9 |
288 |
1.797e-06 |
4.02e-05 |
208 |
NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS |
10 |
372 |
1.796e-06 |
4.02e-05 |
209 |
HEART DEVELOPMENT |
11 |
466 |
1.863e-06 |
4.147e-05 |
210 |
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS |
8 |
218 |
2.134e-06 |
4.729e-05 |
211 |
NEGATIVE REGULATION OF REPRODUCTIVE PROCESS |
5 |
54 |
2.158e-06 |
4.758e-05 |
212 |
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
6 |
98 |
2.291e-06 |
5.028e-05 |
213 |
ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS |
7 |
154 |
2.34e-06 |
5.111e-05 |
214 |
REGULATION OF KIDNEY DEVELOPMENT |
5 |
55 |
2.366e-06 |
5.145e-05 |
215 |
REGULATION OF LEUKOCYTE MEDIATED IMMUNITY |
7 |
156 |
2.55e-06 |
5.518e-05 |
216 |
SECRETION |
12 |
588 |
2.76e-06 |
5.945e-05 |
217 |
RESPONSE TO PURINE CONTAINING COMPOUND |
7 |
158 |
2.775e-06 |
5.95e-05 |
218 |
CELL FATE COMMITMENT |
8 |
227 |
2.883e-06 |
6.154e-05 |
219 |
REGULATION OF TYPE 2 IMMUNE RESPONSE |
4 |
26 |
2.998e-06 |
6.369e-05 |
220 |
REGULATION OF INTERLEUKIN 6 PRODUCTION |
6 |
104 |
3.242e-06 |
6.857e-05 |
221 |
REGULATION OF PROTEIN LOCALIZATION |
15 |
950 |
3.338e-06 |
7.028e-05 |
222 |
RESPONSE TO OXYGEN LEVELS |
9 |
311 |
3.371e-06 |
7.065e-05 |
223 |
INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS |
4 |
27 |
3.509e-06 |
7.256e-05 |
224 |
NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS |
4 |
27 |
3.509e-06 |
7.256e-05 |
225 |
REGULATION OF VASCULATURE DEVELOPMENT |
8 |
233 |
3.498e-06 |
7.256e-05 |
226 |
RESPONSE TO CYTOKINE |
13 |
714 |
3.562e-06 |
7.334e-05 |
227 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
15 |
957 |
3.651e-06 |
7.483e-05 |
228 |
REGULATION OF T CELL DIFFERENTIATION |
6 |
107 |
3.826e-06 |
7.808e-05 |
229 |
EPIDERMIS MORPHOGENESIS |
4 |
29 |
4.721e-06 |
9.592e-05 |
230 |
PATTERN SPECIFICATION PROCESS |
10 |
418 |
5.062e-06 |
0.0001024 |
231 |
GLIOGENESIS |
7 |
175 |
5.454e-06 |
0.0001099 |
232 |
REGULATION OF ENDOTHELIAL CELL MIGRATION |
6 |
114 |
5.525e-06 |
0.0001108 |
233 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
13 |
750 |
6.074e-06 |
0.0001213 |
234 |
REGULATION OF OSSIFICATION |
7 |
178 |
6.099e-06 |
0.0001213 |
235 |
CELL DEATH |
15 |
1001 |
6.294e-06 |
0.0001246 |
236 |
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
5 |
67 |
6.334e-06 |
0.0001249 |
237 |
RESPONSE TO DRUG |
10 |
431 |
6.624e-06 |
0.0001301 |
238 |
REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN |
5 |
68 |
6.816e-06 |
0.0001327 |
239 |
REGULATION OF ALPHA BETA T CELL ACTIVATION |
5 |
68 |
6.816e-06 |
0.0001327 |
240 |
SALIVARY GLAND DEVELOPMENT |
4 |
32 |
7.084e-06 |
0.0001373 |
241 |
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
10 |
437 |
7.476e-06 |
0.0001443 |
242 |
REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
6 |
122 |
8.17e-06 |
0.0001571 |
243 |
T CELL DIFFERENTIATION |
6 |
123 |
8.563e-06 |
0.000164 |
244 |
POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
4 |
34 |
9.082e-06 |
0.0001718 |
245 |
RESPONSE TO FLUID SHEAR STRESS |
4 |
34 |
9.082e-06 |
0.0001718 |
246 |
CD4 POSITIVE ALPHA BETA T CELL ACTIVATION |
4 |
34 |
9.082e-06 |
0.0001718 |
247 |
KIDNEY EPITHELIUM DEVELOPMENT |
6 |
125 |
9.394e-06 |
0.000177 |
248 |
ACUTE INFLAMMATORY RESPONSE |
5 |
73 |
9.674e-06 |
0.0001808 |
249 |
REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
5 |
73 |
9.674e-06 |
0.0001808 |
250 |
NEGATIVE REGULATION OF TRANSPORT |
10 |
458 |
1.125e-05 |
0.0002086 |
251 |
REGULATION OF REPRODUCTIVE PROCESS |
6 |
129 |
1.125e-05 |
0.0002086 |
252 |
CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT |
4 |
36 |
1.147e-05 |
0.0002117 |
253 |
REGULATION OF APOPTOTIC SIGNALING PATHWAY |
9 |
363 |
1.172e-05 |
0.0002155 |
254 |
REGULATION OF LYMPHOCYTE DIFFERENTIATION |
6 |
132 |
1.283e-05 |
0.0002341 |
255 |
NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
4 |
37 |
1.282e-05 |
0.0002341 |
256 |
EMBRYONIC ORGAN MORPHOGENESIS |
8 |
279 |
1.307e-05 |
0.0002366 |
257 |
NEGATIVE REGULATION OF SECRETION |
7 |
200 |
1.305e-05 |
0.0002366 |
258 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
12 |
689 |
1.374e-05 |
0.0002479 |
259 |
MESENCHYMAL CELL DIFFERENTIATION |
6 |
134 |
1.398e-05 |
0.0002512 |
260 |
REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS |
4 |
38 |
1.429e-05 |
0.0002557 |
261 |
NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT |
5 |
80 |
1.516e-05 |
0.0002692 |
262 |
INSULIN RECEPTOR SIGNALING PATHWAY |
5 |
80 |
1.516e-05 |
0.0002692 |
263 |
RESPONSE TO GROWTH FACTOR |
10 |
475 |
1.541e-05 |
0.0002727 |
264 |
POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
4 |
39 |
1.587e-05 |
0.0002797 |
265 |
REGULATION OF DEVELOPMENTAL GROWTH |
8 |
289 |
1.685e-05 |
0.0002959 |
266 |
ORGAN REGENERATION |
5 |
83 |
1.814e-05 |
0.0003173 |
267 |
HEART MORPHOGENESIS |
7 |
212 |
1.902e-05 |
0.0003314 |
268 |
POSITIVE REGULATION OF OSSIFICATION |
5 |
84 |
1.923e-05 |
0.0003339 |
269 |
POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
8 |
296 |
2.001e-05 |
0.0003445 |
270 |
METANEPHRIC MESENCHYME DEVELOPMENT |
3 |
14 |
2.014e-05 |
0.0003445 |
271 |
POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING |
3 |
14 |
2.014e-05 |
0.0003445 |
272 |
RESPONSE TO LAMINAR FLUID SHEAR STRESS |
3 |
14 |
2.014e-05 |
0.0003445 |
273 |
RHYTHMIC PROCESS |
8 |
298 |
2.1e-05 |
0.0003579 |
274 |
REGULATION OF CELL GROWTH |
9 |
391 |
2.111e-05 |
0.0003585 |
275 |
REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS |
4 |
42 |
2.141e-05 |
0.0003622 |
276 |
RESPONSE TO IONIZING RADIATION |
6 |
145 |
2.189e-05 |
0.0003686 |
277 |
POSITIVE REGULATION OF CELL DEATH |
11 |
605 |
2.194e-05 |
0.0003686 |
278 |
CELLULAR RESPONSE TO CYTOKINE STIMULUS |
11 |
606 |
2.228e-05 |
0.0003729 |
279 |
NEUROGENESIS |
17 |
1402 |
2.255e-05 |
0.000376 |
280 |
REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS |
5 |
87 |
2.281e-05 |
0.0003776 |
281 |
REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
7 |
218 |
2.276e-05 |
0.0003776 |
282 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
10 |
498 |
2.312e-05 |
0.0003815 |
283 |
REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT |
3 |
15 |
2.51e-05 |
0.0004127 |
284 |
CELL DEVELOPMENT |
17 |
1426 |
2.802e-05 |
0.0004591 |
285 |
EXOCRINE SYSTEM DEVELOPMENT |
4 |
45 |
2.824e-05 |
0.0004611 |
286 |
REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
6 |
152 |
2.856e-05 |
0.0004647 |
287 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
6 |
153 |
2.964e-05 |
0.0004805 |
288 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
13 |
872 |
2.999e-05 |
0.0004844 |
289 |
CHEMICAL HOMEOSTASIS |
13 |
874 |
3.071e-05 |
0.0004865 |
290 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
6 |
154 |
3.075e-05 |
0.0004865 |
291 |
CARDIAC RIGHT VENTRICLE MORPHOGENESIS |
3 |
16 |
3.081e-05 |
0.0004865 |
292 |
REGULATION OF ALPHA BETA T CELL DIFFERENTIATION |
4 |
46 |
3.084e-05 |
0.0004865 |
293 |
APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS |
3 |
16 |
3.081e-05 |
0.0004865 |
294 |
CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT |
3 |
16 |
3.081e-05 |
0.0004865 |
295 |
BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS |
3 |
16 |
3.081e-05 |
0.0004865 |
296 |
NEPHRON EPITHELIUM DEVELOPMENT |
5 |
93 |
3.15e-05 |
0.0004952 |
297 |
RESPONSE TO RADIATION |
9 |
413 |
3.242e-05 |
0.0005078 |
298 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
6 |
156 |
3.306e-05 |
0.0005162 |
299 |
REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS |
5 |
94 |
3.317e-05 |
0.0005162 |
300 |
REGULATION OF IMMUNOGLOBULIN PRODUCTION |
4 |
47 |
3.361e-05 |
0.0005213 |
301 |
RESPONSE TO ACID CHEMICAL |
8 |
319 |
3.413e-05 |
0.0005276 |
302 |
POSITIVE REGULATION OF T CELL PROLIFERATION |
5 |
95 |
3.491e-05 |
0.0005378 |
303 |
POSITIVE REGULATION OF WOUND HEALING |
4 |
48 |
3.656e-05 |
0.0005614 |
304 |
NEGATIVE REGULATION OF KIDNEY DEVELOPMENT |
3 |
17 |
3.731e-05 |
0.0005691 |
305 |
BRANCH ELONGATION OF AN EPITHELIUM |
3 |
17 |
3.731e-05 |
0.0005691 |
306 |
REGULATION OF INTERFERON GAMMA PRODUCTION |
5 |
97 |
3.859e-05 |
0.0005868 |
307 |
POSITIVE REGULATION OF GROWTH |
7 |
238 |
3.986e-05 |
0.0006022 |
308 |
EYE DEVELOPMENT |
8 |
326 |
3.98e-05 |
0.0006022 |
309 |
LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE |
5 |
98 |
4.054e-05 |
0.0006105 |
310 |
POSITIVE REGULATION OF HEMOPOIESIS |
6 |
163 |
4.228e-05 |
0.0006346 |
311 |
REGULATION OF KINASE ACTIVITY |
12 |
776 |
4.417e-05 |
0.0006608 |
312 |
REGULATION OF ORGAN MORPHOGENESIS |
7 |
242 |
4.431e-05 |
0.0006608 |
313 |
KIDNEY MESENCHYME DEVELOPMENT |
3 |
18 |
4.464e-05 |
0.0006636 |
314 |
REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
4 |
51 |
4.654e-05 |
0.0006897 |
315 |
REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE |
5 |
101 |
4.686e-05 |
0.0006921 |
316 |
HOMEOSTATIC PROCESS |
16 |
1337 |
4.819e-05 |
0.0007096 |
317 |
NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS |
5 |
102 |
4.912e-05 |
0.000721 |
318 |
TISSUE REGENERATION |
4 |
52 |
5.027e-05 |
0.0007333 |
319 |
NEGATIVE REGULATION OF T CELL PROLIFERATION |
4 |
52 |
5.027e-05 |
0.0007333 |
320 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
5 |
103 |
5.147e-05 |
0.0007484 |
321 |
REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS |
3 |
19 |
5.286e-05 |
0.0007663 |
322 |
REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS |
4 |
53 |
5.421e-05 |
0.0007762 |
323 |
RESPONSE TO CAMP |
5 |
104 |
5.391e-05 |
0.0007762 |
324 |
MESONEPHRIC TUBULE MORPHOGENESIS |
4 |
53 |
5.421e-05 |
0.0007762 |
325 |
CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES |
5 |
104 |
5.391e-05 |
0.0007762 |
326 |
NEGATIVE REGULATION OF NEURON DEATH |
6 |
171 |
5.523e-05 |
0.0007859 |
327 |
REGULATION OF CELL MORPHOGENESIS |
10 |
552 |
5.518e-05 |
0.0007859 |
328 |
REGULATION OF NEURON DIFFERENTIATION |
10 |
554 |
5.687e-05 |
0.0008068 |
329 |
REGULATION OF NEURON DEATH |
7 |
252 |
5.723e-05 |
0.0008094 |
330 |
ALPHA BETA T CELL ACTIVATION |
4 |
54 |
5.838e-05 |
0.0008231 |
331 |
FAT CELL DIFFERENTIATION |
5 |
106 |
5.905e-05 |
0.0008301 |
332 |
TONGUE DEVELOPMENT |
3 |
20 |
6.202e-05 |
0.0008692 |
333 |
HOMEOSTASIS OF NUMBER OF CELLS |
6 |
175 |
6.28e-05 |
0.0008776 |
334 |
EPITHELIAL TO MESENCHYMAL TRANSITION |
4 |
56 |
6.74e-05 |
0.0009369 |
335 |
RESPONSE TO HYDROGEN PEROXIDE |
5 |
109 |
6.745e-05 |
0.0009369 |
336 |
REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE |
4 |
57 |
7.227e-05 |
0.0009979 |
337 |
APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT |
3 |
21 |
7.215e-05 |
0.0009979 |
338 |
SINGLE ORGANISM CELL ADHESION |
9 |
459 |
7.327e-05 |
0.001008 |
339 |
REGULATION OF CHEMOTAXIS |
6 |
180 |
7.341e-05 |
0.001008 |
340 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
5 |
112 |
7.676e-05 |
0.00105 |
341 |
CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS |
4 |
58 |
7.74e-05 |
0.001053 |
342 |
REGULATION OF INTERLEUKIN 1 PRODUCTION |
4 |
58 |
7.74e-05 |
0.001053 |
343 |
REGULATION OF PROTEIN IMPORT |
6 |
183 |
8.043e-05 |
0.001082 |
344 |
SEX DIFFERENTIATION |
7 |
266 |
8.037e-05 |
0.001082 |
345 |
POSITIVE REGULATION OF INFLAMMATORY RESPONSE |
5 |
113 |
8.007e-05 |
0.001082 |
346 |
REGULATION OF STEM CELL DIFFERENTIATION |
5 |
113 |
8.007e-05 |
0.001082 |
347 |
NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE |
3 |
22 |
8.331e-05 |
0.001104 |
348 |
REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY |
5 |
114 |
8.349e-05 |
0.001104 |
349 |
VASCULOGENESIS |
4 |
59 |
8.278e-05 |
0.001104 |
350 |
REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION |
6 |
184 |
8.289e-05 |
0.001104 |
351 |
EMBRYONIC PLACENTA MORPHOGENESIS |
3 |
22 |
8.331e-05 |
0.001104 |
352 |
POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT |
3 |
22 |
8.331e-05 |
0.001104 |
353 |
NEPHRON DEVELOPMENT |
5 |
115 |
8.702e-05 |
0.001147 |
354 |
T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE |
4 |
60 |
8.843e-05 |
0.001153 |
355 |
PEPTIDYL TYROSINE MODIFICATION |
6 |
186 |
8.798e-05 |
0.001153 |
356 |
POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
4 |
60 |
8.843e-05 |
0.001153 |
357 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
9 |
470 |
8.778e-05 |
0.001153 |
358 |
CELLULAR RESPONSE TO STRESS |
17 |
1565 |
8.996e-05 |
0.001169 |
359 |
PROTEIN SECRETION |
5 |
116 |
9.066e-05 |
0.001172 |
360 |
HUMORAL IMMUNE RESPONSE |
6 |
187 |
9.062e-05 |
0.001172 |
361 |
CELLULAR RESPONSE TO HYDROGEN PEROXIDE |
4 |
61 |
9.436e-05 |
0.00121 |
362 |
REGULATION OF INTERLEUKIN 8 PRODUCTION |
4 |
61 |
9.436e-05 |
0.00121 |
363 |
MAMMARY GLAND DEVELOPMENT |
5 |
117 |
9.442e-05 |
0.00121 |
364 |
CRANIAL NERVE MORPHOGENESIS |
3 |
23 |
9.553e-05 |
0.001218 |
365 |
REGULATION OF METANEPHROS DEVELOPMENT |
3 |
23 |
9.553e-05 |
0.001218 |
366 |
STEM CELL DIFFERENTIATION |
6 |
190 |
9.891e-05 |
0.001257 |
367 |
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
4 |
62 |
0.0001006 |
0.001275 |
368 |
RESPONSE TO REACTIVE OXYGEN SPECIES |
6 |
191 |
0.0001018 |
0.001287 |
369 |
POSITIVE REGULATION OF CHEMOTAXIS |
5 |
120 |
0.0001064 |
0.001342 |
370 |
REGULATION OF CELL KILLING |
4 |
63 |
0.0001071 |
0.001347 |
371 |
NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION |
3 |
24 |
0.0001089 |
0.001362 |
372 |
REGULATION OF ISOTYPE SWITCHING |
3 |
24 |
0.0001089 |
0.001362 |
373 |
CONNECTIVE TISSUE DEVELOPMENT |
6 |
194 |
0.0001109 |
0.00138 |
374 |
NEGATIVE REGULATION OF IMMUNE RESPONSE |
5 |
121 |
0.0001107 |
0.00138 |
375 |
REGULATION OF ADAPTIVE IMMUNE RESPONSE |
5 |
123 |
0.0001196 |
0.001484 |
376 |
REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
4 |
65 |
0.000121 |
0.001497 |
377 |
LENS FIBER CELL DIFFERENTIATION |
3 |
25 |
0.0001234 |
0.001511 |
378 |
POSITIVE REGULATION OF COAGULATION |
3 |
25 |
0.0001234 |
0.001511 |
379 |
POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
3 |
25 |
0.0001234 |
0.001511 |
380 |
PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
3 |
25 |
0.0001234 |
0.001511 |
381 |
LENS DEVELOPMENT IN CAMERA TYPE EYE |
4 |
66 |
0.0001284 |
0.001568 |
382 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
10 |
616 |
0.0001365 |
0.001658 |
383 |
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
4 |
67 |
0.0001362 |
0.001658 |
384 |
DEVELOPMENTAL PROGRAMMED CELL DEATH |
3 |
26 |
0.0001391 |
0.001676 |
385 |
REGULATION OF MESONEPHROS DEVELOPMENT |
3 |
26 |
0.0001391 |
0.001676 |
386 |
CELLULAR RESPONSE TO INTERLEUKIN 4 |
3 |
26 |
0.0001391 |
0.001676 |
387 |
ORGAN GROWTH |
4 |
68 |
0.0001442 |
0.001734 |
388 |
ANGIOGENESIS |
7 |
293 |
0.0001465 |
0.001757 |
389 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
5 |
129 |
0.0001496 |
0.001789 |
390 |
NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION |
4 |
69 |
0.0001527 |
0.001822 |
391 |
CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS |
3 |
27 |
0.000156 |
0.001852 |
392 |
AXIS ELONGATION |
3 |
27 |
0.000156 |
0.001852 |
393 |
POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION |
5 |
131 |
0.0001607 |
0.001903 |
394 |
POSITIVE REGULATION OF CELL DIVISION |
5 |
132 |
0.0001666 |
0.001967 |
395 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
9 |
513 |
0.0001698 |
0.002001 |
396 |
SKIN EPIDERMIS DEVELOPMENT |
4 |
71 |
0.0001706 |
0.002003 |
397 |
RESPONSE TO MECHANICAL STIMULUS |
6 |
210 |
0.0001709 |
0.002003 |
398 |
POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE |
3 |
28 |
0.0001743 |
0.002012 |
399 |
REGULATION OF KERATINOCYTE PROLIFERATION |
3 |
28 |
0.0001743 |
0.002012 |
400 |
REGULATION OF NEUROBLAST PROLIFERATION |
3 |
28 |
0.0001743 |
0.002012 |
401 |
REGULATION OF SPROUTING ANGIOGENESIS |
3 |
28 |
0.0001743 |
0.002012 |
402 |
RESPONSE TO GONADOTROPIN |
3 |
28 |
0.0001743 |
0.002012 |
403 |
METANEPHROS MORPHOGENESIS |
3 |
28 |
0.0001743 |
0.002012 |
404 |
SKIN DEVELOPMENT |
6 |
211 |
0.0001753 |
0.002019 |
405 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
7 |
303 |
0.00018 |
0.002069 |
406 |
MULTI MULTICELLULAR ORGANISM PROCESS |
6 |
213 |
0.0001845 |
0.002115 |
407 |
CELLULAR RESPONSE TO KETONE |
4 |
73 |
0.00019 |
0.002172 |
408 |
RESPONSE TO ETHANOL |
5 |
136 |
0.0001915 |
0.002184 |
409 |
NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE |
3 |
29 |
0.0001938 |
0.002194 |
410 |
REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION |
3 |
29 |
0.0001938 |
0.002194 |
411 |
T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE |
3 |
29 |
0.0001938 |
0.002194 |
412 |
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS |
6 |
216 |
0.000199 |
0.002248 |
413 |
REGULATION OF ACUTE INFLAMMATORY RESPONSE |
4 |
74 |
0.0002002 |
0.002256 |
414 |
RESPONSE TO ORGANOPHOSPHORUS |
5 |
139 |
0.000212 |
0.00236 |
415 |
ARTERY DEVELOPMENT |
4 |
75 |
0.0002109 |
0.00236 |
416 |
CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE |
5 |
139 |
0.000212 |
0.00236 |
417 |
ODONTOGENESIS OF DENTIN CONTAINING TOOTH |
4 |
75 |
0.0002109 |
0.00236 |
418 |
REGIONALIZATION |
7 |
311 |
0.0002112 |
0.00236 |
419 |
REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
6 |
220 |
0.0002198 |
0.00244 |
420 |
PLATELET ACTIVATION |
5 |
142 |
0.0002341 |
0.002593 |
421 |
REGULATION OF INTERLEUKIN 4 PRODUCTION |
3 |
31 |
0.0002371 |
0.002604 |
422 |
RESPONSE TO INTERLEUKIN 4 |
3 |
31 |
0.0002371 |
0.002604 |
423 |
REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION |
3 |
31 |
0.0002371 |
0.002604 |
424 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
8 |
422 |
0.0002373 |
0.002604 |
425 |
REGULATION OF MAP KINASE ACTIVITY |
7 |
319 |
0.0002465 |
0.002699 |
426 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
9 |
541 |
0.000252 |
0.002746 |
427 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
9 |
541 |
0.000252 |
0.002746 |
428 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
13 |
1079 |
0.0002558 |
0.002781 |
429 |
REGULATION OF ORGAN FORMATION |
3 |
32 |
0.0002609 |
0.00283 |
430 |
POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION |
4 |
80 |
0.0002704 |
0.002926 |
431 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
6 |
229 |
0.0002726 |
0.002943 |
432 |
MUSCLE STRUCTURE DEVELOPMENT |
8 |
432 |
0.0002778 |
0.002992 |
433 |
DIGESTIVE SYSTEM DEVELOPMENT |
5 |
148 |
0.0002836 |
0.003034 |
434 |
RESPONSE TO TEMPERATURE STIMULUS |
5 |
148 |
0.0002836 |
0.003034 |
435 |
POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING |
4 |
81 |
0.0002836 |
0.003034 |
436 |
REGULATION OF TRANSFERASE ACTIVITY |
12 |
946 |
0.0002846 |
0.003037 |
437 |
RESPONSE TO DEXAMETHASONE |
3 |
33 |
0.0002862 |
0.003047 |
438 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
8 |
437 |
0.0003001 |
0.003188 |
439 |
HAIR CYCLE |
4 |
83 |
0.0003114 |
0.003293 |
440 |
MOLTING CYCLE |
4 |
83 |
0.0003114 |
0.003293 |
441 |
PROTEIN KINASE B SIGNALING |
3 |
34 |
0.000313 |
0.003295 |
442 |
HEART VALVE DEVELOPMENT |
3 |
34 |
0.000313 |
0.003295 |
443 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
6 |
236 |
0.0003203 |
0.003353 |
444 |
REGULATION OF MUSCLE CELL DIFFERENTIATION |
5 |
152 |
0.0003207 |
0.003353 |
445 |
NEGATIVE REGULATION OF GROWTH |
6 |
236 |
0.0003203 |
0.003353 |
446 |
TISSUE MIGRATION |
4 |
84 |
0.000326 |
0.003401 |
447 |
TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER |
5 |
153 |
0.0003305 |
0.003441 |
448 |
REGULATION OF ERK1 AND ERK2 CASCADE |
6 |
238 |
0.0003351 |
0.00348 |
449 |
CARDIAC SEPTUM DEVELOPMENT |
4 |
85 |
0.0003411 |
0.003506 |
450 |
AMEBOIDAL TYPE CELL MIGRATION |
5 |
154 |
0.0003406 |
0.003506 |
451 |
PALATE DEVELOPMENT |
4 |
85 |
0.0003411 |
0.003506 |
452 |
BONE REMODELING |
3 |
35 |
0.0003414 |
0.003506 |
453 |
NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION |
3 |
35 |
0.0003414 |
0.003506 |
454 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
7 |
337 |
0.0003435 |
0.003521 |
455 |
POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION |
8 |
448 |
0.0003544 |
0.003624 |
456 |
POSITIVE REGULATION OF DNA REPLICATION |
4 |
86 |
0.0003567 |
0.003632 |
457 |
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
4 |
86 |
0.0003567 |
0.003632 |
458 |
NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT |
3 |
36 |
0.0003714 |
0.00374 |
459 |
REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING |
3 |
36 |
0.0003714 |
0.00374 |
460 |
T CELL SELECTION |
3 |
36 |
0.0003714 |
0.00374 |
461 |
POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS |
3 |
36 |
0.0003714 |
0.00374 |
462 |
POSITIVE CHEMOTAXIS |
3 |
36 |
0.0003714 |
0.00374 |
463 |
MYELOID CELL HOMEOSTASIS |
4 |
88 |
0.0003894 |
0.003897 |
464 |
LEUKOCYTE PROLIFERATION |
4 |
88 |
0.0003894 |
0.003897 |
465 |
POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
4 |
88 |
0.0003894 |
0.003897 |
466 |
POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN |
3 |
37 |
0.000403 |
0.004024 |
467 |
RESPONSE TO HEAT |
4 |
89 |
0.0004065 |
0.004042 |
468 |
EPITHELIAL CELL PROLIFERATION |
4 |
89 |
0.0004065 |
0.004042 |
469 |
REGULATION OF DNA REPLICATION |
5 |
161 |
0.0004176 |
0.004144 |
470 |
HEAD DEVELOPMENT |
10 |
709 |
0.0004204 |
0.004162 |
471 |
CELL CHEMOTAXIS |
5 |
162 |
0.0004296 |
0.004235 |
472 |
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
5 |
162 |
0.0004296 |
0.004235 |
473 |
REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION |
3 |
38 |
0.0004363 |
0.004265 |
474 |
CYTOKINE SECRETION |
3 |
38 |
0.0004363 |
0.004265 |
475 |
MESENCHYME MORPHOGENESIS |
3 |
38 |
0.0004363 |
0.004265 |
476 |
POSITIVE REGULATION OF ORGAN GROWTH |
3 |
38 |
0.0004363 |
0.004265 |
477 |
COGNITION |
6 |
251 |
0.0004444 |
0.004335 |
478 |
REGULATION OF CELLULAR AMIDE METABOLIC PROCESS |
7 |
354 |
0.0004613 |
0.004481 |
479 |
INNER EAR MORPHOGENESIS |
4 |
92 |
0.0004611 |
0.004481 |
480 |
EPIDERMIS DEVELOPMENT |
6 |
253 |
0.0004635 |
0.004493 |
481 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
13 |
1152 |
0.0004794 |
0.004638 |
482 |
REGULATION OF DNA BINDING |
4 |
93 |
0.0004804 |
0.004638 |
483 |
FOREBRAIN DEVELOPMENT |
7 |
357 |
0.0004851 |
0.004673 |
484 |
REGULATION OF MULTI ORGANISM PROCESS |
8 |
470 |
0.000487 |
0.004682 |
485 |
MAMMARY GLAND MORPHOGENESIS |
3 |
40 |
0.0005081 |
0.004855 |
486 |
REGULATION OF ACTIVATED T CELL PROLIFERATION |
3 |
40 |
0.0005081 |
0.004855 |
487 |
RESPONSE TO CARBOHYDRATE |
5 |
168 |
0.0005072 |
0.004855 |
488 |
APPENDAGE DEVELOPMENT |
5 |
169 |
0.0005211 |
0.004958 |
489 |
LIMB DEVELOPMENT |
5 |
169 |
0.0005211 |
0.004958 |
490 |
NEGATIVE REGULATION OF CELL GROWTH |
5 |
170 |
0.0005353 |
0.005062 |
491 |
GLUCOSE HOMEOSTASIS |
5 |
170 |
0.0005353 |
0.005062 |
492 |
CARBOHYDRATE HOMEOSTASIS |
5 |
170 |
0.0005353 |
0.005062 |
493 |
MYELOID LEUKOCYTE DIFFERENTIATION |
4 |
96 |
0.0005418 |
0.005114 |
494 |
REGULATION OF HORMONE LEVELS |
8 |
478 |
0.0005442 |
0.005118 |
495 |
POSITIVE REGULATION OF DEFENSE RESPONSE |
7 |
364 |
0.0005444 |
0.005118 |
496 |
POSITIVE REGULATION OF KIDNEY DEVELOPMENT |
3 |
41 |
0.0005467 |
0.005119 |
497 |
REGULATION OF B CELL MEDIATED IMMUNITY |
3 |
41 |
0.0005467 |
0.005119 |
498 |
RESPONSE TO INORGANIC SUBSTANCE |
8 |
479 |
0.0005517 |
0.005155 |
499 |
REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
5 |
172 |
0.0005645 |
0.005253 |
500 |
POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE |
5 |
172 |
0.0005645 |
0.005253 |
501 |
REGULATION OF CYTOPLASMIC TRANSPORT |
8 |
481 |
0.000567 |
0.005266 |
502 |
NEGATIVE REGULATION OF LOCOMOTION |
6 |
263 |
0.0005684 |
0.005269 |
503 |
POSITIVE REGULATION OF KINASE ACTIVITY |
8 |
482 |
0.0005748 |
0.005307 |
504 |
ORGANIC HYDROXY COMPOUND METABOLIC PROCESS |
8 |
482 |
0.0005748 |
0.005307 |
505 |
POSITIVE REGULATION OF DNA BINDING |
3 |
42 |
0.0005871 |
0.005399 |
506 |
DETECTION OF MECHANICAL STIMULUS |
3 |
42 |
0.0005871 |
0.005399 |
507 |
CELL CELL ADHESION |
9 |
608 |
0.0005888 |
0.005404 |
508 |
LIPID PHOSPHORYLATION |
4 |
99 |
0.0006086 |
0.005574 |
509 |
CELLULAR RESPONSE TO ACID CHEMICAL |
5 |
175 |
0.0006105 |
0.005581 |
510 |
CRANIAL NERVE DEVELOPMENT |
3 |
43 |
0.0006294 |
0.005709 |
511 |
REGULATION OF POLYSACCHARIDE METABOLIC PROCESS |
3 |
43 |
0.0006294 |
0.005709 |
512 |
REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY |
3 |
43 |
0.0006294 |
0.005709 |
513 |
ACUTE PHASE RESPONSE |
3 |
43 |
0.0006294 |
0.005709 |
514 |
REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
4 |
100 |
0.0006321 |
0.005722 |
515 |
REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION |
4 |
101 |
0.0006562 |
0.005929 |
516 |
TYROSINE PHOSPHORYLATION OF STAT PROTEIN |
2 |
10 |
0.0006621 |
0.005971 |
517 |
LABYRINTHINE LAYER DEVELOPMENT |
3 |
44 |
0.0006736 |
0.006027 |
518 |
BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS |
3 |
44 |
0.0006736 |
0.006027 |
519 |
REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN |
3 |
44 |
0.0006736 |
0.006027 |
520 |
NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION |
3 |
44 |
0.0006736 |
0.006027 |
521 |
REGULATION OF INTRACELLULAR TRANSPORT |
9 |
621 |
0.0006848 |
0.006116 |
522 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
4 |
103 |
0.0007064 |
0.006297 |
523 |
CELLULAR COMPONENT MORPHOGENESIS |
11 |
900 |
0.0007106 |
0.006322 |
524 |
REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
7 |
381 |
0.0007128 |
0.00633 |
525 |
ALPHA BETA T CELL DIFFERENTIATION |
3 |
45 |
0.0007197 |
0.006378 |
526 |
CARDIAC CHAMBER MORPHOGENESIS |
4 |
104 |
0.0007325 |
0.006443 |
527 |
RESPONSE TO KETONE |
5 |
182 |
0.0007289 |
0.006443 |
528 |
POSITIVE REGULATION OF PROTEIN IMPORT |
4 |
104 |
0.0007325 |
0.006443 |
529 |
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS |
4 |
104 |
0.0007325 |
0.006443 |
530 |
SINGLE ORGANISM BEHAVIOR |
7 |
384 |
0.0007464 |
0.006534 |
531 |
MUSCLE ORGAN DEVELOPMENT |
6 |
277 |
0.0007455 |
0.006534 |
532 |
REGULATION OF MYELOID CELL DIFFERENTIATION |
5 |
183 |
0.0007471 |
0.006534 |
533 |
REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
6 |
278 |
0.0007596 |
0.006619 |
534 |
ODONTOGENESIS |
4 |
105 |
0.0007593 |
0.006619 |
535 |
CELLULAR RESPONSE TO OXIDATIVE STRESS |
5 |
184 |
0.0007656 |
0.006659 |
536 |
NEGATIVE REGULATION OF CYTOKINE SECRETION |
3 |
46 |
0.0007677 |
0.006665 |
537 |
DEFENSE RESPONSE TO OTHER ORGANISM |
8 |
505 |
0.000779 |
0.00675 |
538 |
MULTICELLULAR ORGANISM REPRODUCTION |
10 |
768 |
0.0007812 |
0.006756 |
539 |
POSITIVE REGULATION OF DNA METABOLIC PROCESS |
5 |
185 |
0.0007845 |
0.006773 |
540 |
REGULATION OF GLUCOSE METABOLIC PROCESS |
4 |
106 |
0.0007868 |
0.006779 |
541 |
EPITHELIAL CELL DEVELOPMENT |
5 |
186 |
0.0008038 |
0.006867 |
542 |
REGULATION OF T HELPER 2 CELL DIFFERENTIATION |
2 |
11 |
0.0008072 |
0.006867 |
543 |
REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY |
2 |
11 |
0.0008072 |
0.006867 |
544 |
NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE |
2 |
11 |
0.0008072 |
0.006867 |
545 |
BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS |
2 |
11 |
0.0008072 |
0.006867 |
546 |
EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION |
2 |
11 |
0.0008072 |
0.006867 |
547 |
LYMPHOID PROGENITOR CELL DIFFERENTIATION |
2 |
11 |
0.0008072 |
0.006867 |
548 |
PLATELET DEGRANULATION |
4 |
107 |
0.0008149 |
0.006919 |
549 |
NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY |
3 |
47 |
0.0008178 |
0.006921 |
550 |
POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT |
6 |
282 |
0.0008181 |
0.006921 |
551 |
NEGATIVE REGULATION OF PROTEIN SECRETION |
4 |
108 |
0.0008438 |
0.007126 |
552 |
MYELOID CELL DIFFERENTIATION |
5 |
189 |
0.0008636 |
0.00728 |
553 |
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
3 |
48 |
0.0008699 |
0.007293 |
554 |
REGULATION OF MYOBLAST DIFFERENTIATION |
3 |
48 |
0.0008699 |
0.007293 |
555 |
DIGESTIVE TRACT MORPHOGENESIS |
3 |
48 |
0.0008699 |
0.007293 |
556 |
POSITIVE REGULATION OF LEUKOCYTE MIGRATION |
4 |
109 |
0.0008734 |
0.007309 |
557 |
RESPONSE TO NUTRIENT |
5 |
191 |
0.0009053 |
0.007563 |
558 |
PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS |
3 |
49 |
0.000924 |
0.007664 |
559 |
REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
3 |
49 |
0.000924 |
0.007664 |
560 |
LYMPHOCYTE MIGRATION |
3 |
49 |
0.000924 |
0.007664 |
561 |
CARDIAC SEPTUM MORPHOGENESIS |
3 |
49 |
0.000924 |
0.007664 |
562 |
REGULATION OF NEURON APOPTOTIC PROCESS |
5 |
192 |
0.0009267 |
0.007673 |
563 |
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
6 |
289 |
0.0009289 |
0.007677 |
564 |
KERATINOCYTE PROLIFERATION |
2 |
12 |
0.0009662 |
0.007848 |
565 |
POSITIVE REGULATION OF CELLULAR EXTRAVASATION |
2 |
12 |
0.0009662 |
0.007848 |
566 |
ANATOMICAL STRUCTURE REGRESSION |
2 |
12 |
0.0009662 |
0.007848 |
567 |
REGULATION OF FEMALE GONAD DEVELOPMENT |
2 |
12 |
0.0009662 |
0.007848 |
568 |
DISTAL TUBULE DEVELOPMENT |
2 |
12 |
0.0009662 |
0.007848 |
569 |
TROPHOBLAST GIANT CELL DIFFERENTIATION |
2 |
12 |
0.0009662 |
0.007848 |
570 |
EAR MORPHOGENESIS |
4 |
112 |
0.0009665 |
0.007848 |
571 |
RESPONSE TO AMINO ACID |
4 |
112 |
0.0009665 |
0.007848 |
572 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS |
2 |
12 |
0.0009662 |
0.007848 |
573 |
NEGATIVE REGULATION OF RECEPTOR BINDING |
2 |
12 |
0.0009662 |
0.007848 |
574 |
RESPONSE TO GAMMA RADIATION |
3 |
50 |
0.0009802 |
0.007946 |
575 |
OVULATION CYCLE |
4 |
113 |
0.000999 |
0.008084 |
576 |
POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION |
3 |
51 |
0.001039 |
0.008303 |
577 |
POSITIVE REGULATION OF FAT CELL DIFFERENTIATION |
3 |
51 |
0.001039 |
0.008303 |
578 |
ARTERY MORPHOGENESIS |
3 |
51 |
0.001039 |
0.008303 |
579 |
NOTCH SIGNALING PATHWAY |
4 |
114 |
0.001032 |
0.008303 |
580 |
NEGATIVE REGULATION OF CALCIUM ION TRANSPORT |
3 |
51 |
0.001039 |
0.008303 |
581 |
REGULATION OF EMBRYONIC DEVELOPMENT |
4 |
114 |
0.001032 |
0.008303 |
582 |
POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION |
3 |
51 |
0.001039 |
0.008303 |
583 |
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
4 |
115 |
0.001066 |
0.008496 |
584 |
RESPONSE TO INTERLEUKIN 1 |
4 |
115 |
0.001066 |
0.008496 |
585 |
FEMALE SEX DIFFERENTIATION |
4 |
116 |
0.001101 |
0.008759 |
586 |
SMALL MOLECULE METABOLIC PROCESS |
16 |
1767 |
0.001135 |
0.008938 |
587 |
LEUKOCYTE CHEMOTAXIS |
4 |
117 |
0.001137 |
0.008938 |
588 |
REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT |
2 |
13 |
0.001139 |
0.008938 |
589 |
POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION |
2 |
13 |
0.001139 |
0.008938 |
590 |
CELLULAR RESPONSE TO HEPATOCYTE GROWTH FACTOR STIMULUS |
2 |
13 |
0.001139 |
0.008938 |
591 |
RESPONSE TO HEPATOCYTE GROWTH FACTOR |
2 |
13 |
0.001139 |
0.008938 |
592 |
MESENCHYMAL CELL PROLIFERATION |
2 |
13 |
0.001139 |
0.008938 |
593 |
REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS |
2 |
13 |
0.001139 |
0.008938 |
594 |
REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE |
3 |
53 |
0.001162 |
0.009042 |
595 |
POSITIVE REGULATION OF FIBROBLAST PROLIFERATION |
3 |
53 |
0.001162 |
0.009042 |
596 |
MAMMARY GLAND EPITHELIUM DEVELOPMENT |
3 |
53 |
0.001162 |
0.009042 |
597 |
NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION |
3 |
53 |
0.001162 |
0.009042 |
598 |
DNA TEMPLATED TRANSCRIPTION INITIATION |
5 |
202 |
0.001162 |
0.009042 |
599 |
REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
4 |
118 |
0.001173 |
0.009099 |
600 |
MESODERM DEVELOPMENT |
4 |
118 |
0.001173 |
0.009099 |
601 |
GLUCOSE METABOLIC PROCESS |
4 |
119 |
0.001211 |
0.009372 |
602 |
REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS |
3 |
54 |
0.001227 |
0.00945 |
603 |
VENTRICULAR SEPTUM DEVELOPMENT |
3 |
54 |
0.001227 |
0.00945 |
604 |
MONOSACCHARIDE TRANSPORT |
3 |
54 |
0.001227 |
0.00945 |
605 |
REGULATION OF SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM |
5 |
205 |
0.001241 |
0.009541 |
606 |
CELLULAR HOMEOSTASIS |
9 |
676 |
0.001244 |
0.009549 |
607 |
POSITIVE REGULATION OF NEURON DIFFERENTIATION |
6 |
306 |
0.001246 |
0.009551 |
608 |
CYTOKINE PRODUCTION |
4 |
120 |
0.001249 |
0.009556 |
609 |
SYSTEM PROCESS |
16 |
1785 |
0.001263 |
0.009651 |
610 |
REGULATION OF PROTEIN TARGETING |
6 |
307 |
0.001267 |
0.009664 |
611 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
4 |
121 |
0.001288 |
0.009757 |
612 |
POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
4 |
121 |
0.001288 |
0.009757 |
613 |
REGULATION OF B CELL ACTIVATION |
4 |
121 |
0.001288 |
0.009757 |
614 |
REGULATION OF PROTEIN KINASE B SIGNALING |
4 |
121 |
0.001288 |
0.009757 |
615 |
NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION |
3 |
55 |
0.001294 |
0.009757 |
616 |
CRANIAL SKELETAL SYSTEM DEVELOPMENT |
3 |
55 |
0.001294 |
0.009757 |
617 |
ACTIN CYTOSKELETON REORGANIZATION |
3 |
55 |
0.001294 |
0.009757 |
618 |
POSITIVE REGULATION OF CHOLESTEROL EFFLUX |
2 |
14 |
0.001326 |
0.009853 |
619 |
SPECIFICATION OF ORGAN IDENTITY |
2 |
14 |
0.001326 |
0.009853 |
620 |
POSITIVE REGULATION OF HISTONE DEACETYLATION |
2 |
14 |
0.001326 |
0.009853 |
621 |
POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE |
2 |
14 |
0.001326 |
0.009853 |
622 |
INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
2 |
14 |
0.001326 |
0.009853 |
623 |
REGULATION OF FIBRINOLYSIS |
2 |
14 |
0.001326 |
0.009853 |
624 |
POSITIVE REGULATION OF SPROUTING ANGIOGENESIS |
2 |
14 |
0.001326 |
0.009853 |
625 |
CRANIOFACIAL SUTURE MORPHOGENESIS |
2 |
14 |
0.001326 |
0.009853 |
626 |
REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY |
2 |
14 |
0.001326 |
0.009853 |
627 |
REGULATION OF WNT SIGNALING PATHWAY |
6 |
310 |
0.001331 |
0.009881 |
628 |
REGULATION OF CALCIUM ION TRANSPORT |
5 |
209 |
0.001351 |
0.009997 |
629 |
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
5 |
209 |
0.001351 |
0.009997 |